The US IPO market saw 25 newcomers in September 2018, raising a combined capital of around $6.4 billion. Amidst the US-China trade tensions, around seven Chinese companies stepped into the US market, including Chinese electric-car maker NIO Inc. (NIO), which is likely to compete with Tesla (TSLA) in the luxury electric-car market in the US.
With October’s average IPO production (for last 17 years) being just 19.3 deals per month, the first week of October 2018 is already set for six IPOs to raise about $783.49 million in capital, according to IPOScoop.
Here’s the list of companies that went public during September 2018:
Gores Holdings III, Inc. (NASDAQ: GRSHU)
IPO Date: Sep. 07, 2018
IPO Price: $10.00
Amount Raised: $375 million
Founded in 2017, Gores Holdings III, a blank check company, formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company raised $375 million by selling 37.5 million shares. At the close of the first trading day, the stock was up 12% at $10.15.
Churchill Capital Corp (NYSE: CCC.U)
IPO Date: Sep. 07, 2018
IPO Price: $10.00
Amount Raised: $600 million
Founded in 2018, Churchill Capital, a blank check company, formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company raised $600 million by selling 60 million shares. At the close of the first trading day, the stock was at $10.06.
NIO Inc. (NYSE: NIO)
IPO Date: Sep. 12, 2018
IPO Price: $6.26
Amount Raised: $1 billion
NIO is a Shanghai-based electric-vehicle manufacturer founded in 2014. The company’s valuation at IPO was $6.4 billion. NIO is likely to compete with Tesla in the US. The company raised $1 billion by selling 160 million shares. At the close of the first trading day, the stock was slightly up at $6.60.
111, Inc. (NASDAQ: YI)
IPO Date: Sep. 12, 2018
IPO Price: $14.00
Amount Raised: $100.5 million
111, Inc. is a Chinese online drugstore founded in 2012. It is one of the first online retail pharmacies in China. The company’s valuation at IPO was $2.3 billion. The company raised $100.5 million by selling 7.2 million shares. At the close of the first trading day, the stock was slightly down at $13.80.
Qutoutiao (NASDAQ: QTT)
IPO Date: Sep. 14, 2018
IPO Price: $7.00
Amount Raised: $84 million
Qutoutiao is a Chinese online news aggregator founded in 2016. Its valuation at IPO was $1.7 billion. The company raised $84 million by selling 12 million shares. At the close of the first trading day, the stock was up 128% at $15.97.
Principia Biopharma (NASDAQ: PRNB)
IPO Date: Sep. 14, 2018
IPO Price: $17.00
Amount Raised: $106.25 million
Principia Biopharma is a clinical-stage biopharmaceutical company founded in 2008. The company’s valuation at IPO was $386 million. It raised $106.25 million by selling 6.25 million shares. At the close of the first trading day, the stock was up 92% at $32.65.
FVCBankcorp (NASDAQ : FVCB)
IPO Date: Sep. 14, 2018
IPO Price: $20.00
Amount Raised: $35 million
FVCBankcorp is the bank holding company for FVCbank founded in 2007. The company’s valuation at IPO was $256.5 million. It raised $35 million by selling 1.75 million shares. The stock closed flat on the first trading day.
X Financial (NYSE : XYF)
IPO Date: Sep. 19, 2018
IPO Price: $9.50
Amount Raised: $104.5 million
X Financial is a China-based peer-to-peer lending platform founded in 2014. The company’s valuation at IPO was $2.9 billion. It raised $104.5 million by selling 11 million shares. The stock closed at $11.91 on the first trading day.
Eventbrite (NYSE : EB)
IPO Date: Sep. 20, 2018
IPO Price: $23.00
Amount Raised: $230 million
Eventbrite is an online ticketing platform founded in 2006. The company’s valuation at IPO was $1.8 billion. It raised $230 million by selling 10 million shares. At the close of the first trading day, the stock was up nearly 59% at $36.50.
Elanco Animal Health (NYSE : ELAN)
IPO Date: Sep. 20, 2018
IPO Price: $24.00
Amount Raised: $1.5 billion
Elanco is a spin-off of animal health unit of pharmaceutical giant Eli Lilly (LLY). Elanco’s valuation at IPO was $8.6 billion. The company raised $1.5 billion by selling 62.9 million shares. The stock closed at $36.00 on the first trading day.
Bank7 (NASDAQ : BSVN)
IPO Date: Sep. 20, 2018
IPO Price: $19.00
Amount Raised: $64.6 million
Bank7 is an Oklahoma City-based bank holding company founded in 1901. The company’s valuation at IPO was $193.5 million. It raised $64.6 million by selling 3.4 million shares. The stock closed at $19.09 on the first trading day.
Y-mAbs Therapeutics (NASDAQ : YMAB)
IPO Date: Sep. 21, 2018
IPO Price: $16.00
Amount Raised: $96 million
YmAbs is a New York-based clinical-stage biopharmaceutical company founded in 2015. The company raised $96 million by selling 6 million shares. The stock closed at $24.00 on the first trading day.
Farfetch Ltd. (NYSE : FTCH)
IPO Date: Sep. 21, 2018
IPO Price: $20.00
Amount Raised: $884.8 million
Farfetch is a London-based online luxury fashion retail platform founded in 2007. Its valuation at IPO was $5.8 billion. The company raised $884.8 million by selling 44.2 million shares. The stock closed at $28.45 on the first trading day.
Viomi Technology Co., Ltd (NASDAQ : VIOT)
IPO Date: Sep. 25, 2018
IPO Price: $9.00
Amount Raised: $102.6 million
Viomi is a China-based smart-home products company founded in 2014. Its valuation at IPO was $1.9 billion. The company raised $102.6 million by selling 11.4 million shares. At the close of the first trading day, the stock was slightly up at $9.08.
SurveyMonkey Inc. (NASDAQ : SVMK)
IPO Date: Sep. 26, 2018
IPO Price: $12.00
Amount Raised: $180 million
SurveyMonkey is an online survey company founded in 1999. The company’s valuation at IPO was $1.5 billion. It raised $180 million by selling 15 million shares. The stock closed at $17.24 on the first trading day.
Entasis Therapeutics Holdings Inc. (NASDAQ : ETTX)
IPO Date: Sep. 25, 2018
IPO Price: $15.00
Amount Raised: $75 million
Entasis Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products. Its valuation at IPO was $196 million. The company raised $75 million by selling 5 million shares. At close of the first trading day, the stock was almost down 29% to $10.66.
Capital Bancorp Inc. (NASDAQ : CBNK)
IPO Date: Sep. 26, 2018
IPO Price: $12.50
Amount Raised: $27.8 million
Capital Bancorp is a bank holding company of Capital Bank, National Association. The company raised $27.8 million by selling 2.2 million shares. At the close of the first trading day, the stock was slightly up at $12.80.
Arco Platform Ltd. (NASDAQ : ARCE)
IPO Date: Sep. 26, 2018
IPO Price: $17.50
Amount Raised: $194.4 million
Arco Platform delivers high-quality educational content in both printed and digital formats to private schools in Brazil to improve the learning process. The company raised $194.4 million by selling 11.1 million shares. The stock opened 40% higher at $24.5 and closed slightly lower at $23.50.
Urovant Sciences Ltd. (NASDAQ : UROV)
IPO Date: Sep. 27, 2018
IPO Price: $14.00
Amount Raised: $140 million
Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing novel therapies for urologic conditions. The company raised $140 million by selling 10 million shares. The stock opened 25% lower at $10.5 and closed slightly higher at $11.65.
Sutro Biopharma, Inc. (NASDAQ : STRO)
IPO Date: Sep. 27, 2018
IPO Price: $15.00
Amount Raised: $85 million
Sutro Biopharma develops antibody-drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its valuation at IPO was $342 million. The company raised $85 million by selling 5.7 million shares. At the close of the first trading day, the stock was slightly up at $15.20.
Ra Medical Systems, Inc. (NYSE : RMED)
IPO Date: Sep. 27, 2018
IPO Price: $17.00
Amount Raised: $66.3 million
Ra Medical Systems is a medical device company which develops excimer lasers for use in the treatment of vascular and dermatological diseases. The company raised $66.3 million by selling 3.9 million shares. The stock opened more than 25% higher at $21.5 and closed slightly lower at $20.00.
Laix Inc. (NYSE : LAIX)
IPO Date: Sep. 27, 2018
IPO Price: $12.50
Amount Raised: $71.8 million
Laix is a Chinese-based artificial intelligence company that creates and delivers products and services to popularize English learning. The company raised $71.8 million by selling 5.75 million shares. The stock opened more than 28% higher at $16 and closed nearly 21% lower at $12.65.
Arvinas Inc. (NASDAQ: ARVN)
IPO Date: Sep. 26, 2018
IPO Price: $16.00
Amount Raised: $120 million
Arvinas is a biotechnology company focused on creating a new class of drugs based on protein degradation to treat cancer and other diseases. Its valuation at IPO was $514.5 million. The company raised $120 million by selling 7.5 million shares. The stock opened more than 31% higher at $21 and closed nearly 24% lower at $16.05.
Gritstone Oncology, Inc. (NASDAQ : GRTS)
IPO Date: Sep. 28, 2018
IPO Price: $15.00
Amount Raised: $100 million
Gritstone Oncology is a next-generation personalized cancer immunotherapy company based in Emeryville, California. The company raised $100 million by selling 6.7 million shares. At the close of the first trading day, the stock was slightly down at $14.24.
CooTek (Cayman) Inc. (NYSE : CTK)
IPO Date: Sep. 28, 2018
IPO Price: $12.00
Amount Raised: $52.2 million
CooTek is a Chinese mobile internet company which provides big data processing and artificial intelligence solutions. The company raised $52.2 million by selling 4.35 million shares. At the close of the first trading day, the stock was down about 18% to $9.44.
Most Popular
Broadcom (AVGO) reports higher Q3 revenue and profit; results beat estimates
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) reported higher revenues and adjusted earnings for the third quarter of 2024 amid continued strong demand. The Q3 numbers also topped expectations. Earnings, excluding
Key takeaways from Hewlett Packard’s (HPE) Q3 2024 earnings report
Hewlett Packard Enterprise (NYSE: HPE) has delivered stronger-than-expected third-quarter results amid significant conversion in AI system revenues. The prospects for the company's AI server and edge computing businesses look promising
Hormel Foods (HRL): Factors that put a damper on the food company’s Q3 performance
Shares of Hormel Foods Corporation (NYSE: HRL) were up over 2% on Thursday. The stock is recovering from a fall it took a day ago after the company delivered mixed
Comments
Comments are closed.